Ann: Medibio Quarterly Update and Cashflow Report, page-17

Thank you @SolomonField.

There is far too much negativity on this forum. Most of it is from the 249D crowd. Understandable I guess but if they just let the company get on with it, we would see the value come back to where it should be.

I acknowledged that there are challenges but one by one they will be overcome. We are all in this together and have a common goal. The best thing that can happen now is for the old crew to step aside gracefully (they've had their go) and let new blood take it from here.

Lets not forget the last trial result of 70% (which can be improved upon), FDA decision immanent and ilumen now in the marketplace.